List of Other Ref. Standards of Taltirelin on PharmaCompass.com.

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 103300-74-9, Taltirelin acetate, Ceredist, Ta 0910, Ta-0910, Taltirelin [inn]
Molecular Formula
C17H23N7O5
Molecular Weight
405.4  g/mol
InChI Key
LQZAIAZUDWIVPM-SRVKXCTJSA-N
FDA UNII
DOZ62MV6A5

Taltirelin
1 2D Structure

Taltirelin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(4S)-N-[(2S)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-1-methyl-2,6-dioxo-1,3-diazinane-4-carboxamide
2.1.2 InChI
InChI=1S/C17H23N7O5/c1-23-13(25)6-10(22-17(23)29)15(27)21-11(5-9-7-19-8-20-9)16(28)24-4-2-3-12(24)14(18)26/h7-8,10-12H,2-6H2,1H3,(H2,18,26)(H,19,20)(H,21,27)(H,22,29)/t10-,11-,12-/m0/s1
2.1.3 InChI Key
LQZAIAZUDWIVPM-SRVKXCTJSA-N
2.1.4 Canonical SMILES
CN1C(=O)CC(NC1=O)C(=O)NC(CC2=CN=CN2)C(=O)N3CCCC3C(=O)N
2.1.5 Isomeric SMILES
CN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N
2.2 Other Identifiers
2.2.1 UNII
DOZ62MV6A5
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (1-methyl-4,5-dihydroorotyl)-histidyl-prolinamide

2. Ta 0910

3. Ta-0910

4. Taltirelin Hydrate

2.3.2 Depositor-Supplied Synonyms

1. 103300-74-9

2. Taltirelin Acetate

3. Ceredist

4. Ta 0910

5. Ta-0910

6. Taltirelin [inn]

7. Doz62mv6a5

8. (s)-n-((s)-1-((s)-2-carbamoylpyrrolidin-1-yl)-3-(1h-imidazol-4-yl)-1-oxopropan-2-yl)-1-methyl-2,6-dioxohexahydropyrimidine-4-carboxamide

9. Ncgc00181033-01

10. (4s)-n-[(2s)-1-[(2s)-2-carbamoylpyrrolidin-1-yl]-3-(3h-imidazol-4-yl)-1-oxopropan-2-yl]-1-methyl-2,6-dioxo-1,3-diazinane-4-carboxamide

11. (4s)-n-[(2s)-1-[(2s)-2-carbamoylpyrrolidin-1-yl]-3-(1h-imidazol-5-yl)-1-oxopropan-2-yl]-1-methyl-2,6-dioxo-1,3-diazinane-4-carboxamide

12. Unii-doz62mv6a5

13. Taltirelina

14. Taltireline

15. Taltirelinum

16. Ccris 8513

17. Taltirelin [mi]

18. Ta-0910, Taltirelin

19. Taltirelin [mart.]

20. (-)-n-(((s)-hexahydro-1-methyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-l-histidyl-l-prolinamide

21. Dsstox_cid_23763

22. Dsstox_rid_80071

23. Taltirelin [who-dd]

24. Dsstox_gsid_43763

25. (1-methyl-4,5-dihydroorotyl)-histidyl-prolinamide

26. Schembl194528

27. Gtpl2143

28. Chembl2107016

29. Dtxsid0043763

30. Schembl21219549

31. Schembl22077031

32. Chebi:135653

33. Bcpp000053

34. Amy22588

35. Bcp02001

36. Hy-b0596

37. Zinc4217500

38. Tox21_112682

39. Akos015920135

40. Akos015969113

41. L-prolinamide, N-(((4s)-hexahydro-1-methyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-l-histidyl-

42. L-prolinamide, N-((hexahydro-1-methyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-l-histidyl-, (s)-

43. N-[[(4s)-hexahydro-1-methyl-2,6-dioxo-4-pyrimidinyl]carbonyl]-l-histidyl-l-prolinamide

44. Ncgc00381723-02

45. Ac-23956

46. Cas-103300-74-9

47. 300t749

48. J-000925

49. Q7680336

50. (1-methyl-(s)-4,5-dihydroorotyl)-l-histidyl-l-prolinamide

51. 1-methyl-(s)-4,5-dihydroorotyl-l-histidyl-l-prolinamide

52. Methyl5-(propan-2-yl)-1,2-oxazole-3-carboxylate

53. N-{[(4s)-1-methyl-2,6-dioxohexahydropyrimidin-4-yl]carbonyl}-l-histidyl-l-prolinamide

54. (s)-n-((s)-1-((s)-2-carbamoylpyrrolidin-1-yl)-3-(1h-imidazol-5-yl)-1-oxopropan-2-yl)-1-methyl-2,6-dioxohexahydropyrimidine-4-carboxamide

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 405.4 g/mol
Molecular Formula C17H23N7O5
XLogP3-3
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count6
Rotatable Bond Count6
Exact Mass405.17606686 g/mol
Monoisotopic Mass405.17606686 g/mol
Topological Polar Surface Area171 Ų
Heavy Atom Count29
Formal Charge0
Complexity714
Isotope Atom Count0
Defined Atom Stereocenter Count3
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Nootropic Agents

Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. (See all compounds classified as Nootropic Agents.)


Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty